What Is Ashwagandha and Why Does Form Matter?
Ashwagandha (Withania somnifera) is an adaptogenic herb used historically to reduce anxiety, improve stress management, and support general wellbeing. Its active compounds β withanolides β are found in both the roots and leaves.
Several different forms are commercially available, differing in withanolide concentration, bioavailability, and scientific evidence base. Choosing the right form matters because it directly affects the effect you get.
Main Forms Compared
| Form | Withanolides | Evidence base | Notes |
|---|---|---|---|
| KSM-66 (root extract) | Standardised up to 5% | Strong β multiple RCTs | Widely studied, dairy-free process |
| Sensoril (root + leaf) | Up to 10% | Good | More withanolides, but different profile |
| Plain root powders | Varies (0.5β3%) | Weaker | Cheaper, less controlled |
| Liquid extract | Varies | Limited | Fast absorption, convenience preference |
Bioavailability Differences
KSM-66 and Sensoril are standardised extracts that guarantee consistent composition from batch to batch. Plain powders can contain widely varying levels of withanolides depending on growing and processing conditions.
In one randomised controlled trial, KSM-66 extract reduced cortisol levels and improved stress management compared to placebo (Chandrasekhar et al., 2012). This is one reason experts tend to prefer standardised extracts.
Cost Per Effective Dose
KSM-66 and Sensoril cost more, but the standardised withanolide amount is higher. With a plain powder you may need to take more to achieve a similar effect β which narrows the price difference in practice.
Considering actual withanolides per serving:
- KSM-66 600 mg capsule: approximately 30 mg withanolides (5%)
- Plain powder 600 mg: may yield under 9 mg (1.5%) or less
Which Form for Which Goal?
- Stress relief and anxiety support β KSM-66 is the best-evidenced choice
- Athletic recovery and endurance β both KSM-66 and Sensoril are suitable
- Lower-budget everyday use β plain powders, if budget is a constraint
- Convenience β capsules vs powder β both effective; powder is more flexible for larger doses
What to Look for on the Label
- Check whether KSM-66 or Sensoril patented extracts are used
- The withanolide percentage should be clearly stated
- Avoid products promising unrealistic results in short timeframes
- Third-party certification (e.g. NSF, Informed Sport) adds safety reassurance
In our ashwagandha category at maxfit.ee you will find OstroVit KSM-66 Ashwagandha VEGE 120caps and MST Ashwagandha KSM66 60caps β both using standardised KSM-66 extract. Also available are
ICONFIT Capsules Ashwagandha N90β¬13.90 In stock and BIOTECHUSA Ashwagandha 60 caps.
FAQ
Is KSM-66 always better than Sensoril?
KSM-66 has been studied more extensively and its evidence base is somewhat broader, especially in stress research. Sensoril has a higher overall withanolide percentage, but both profiles differ slightly. Both are quality choices.
How should ashwagandha be taken?
Most studies have used doses taken with a meal β this improves tolerability and may support absorption. An evening dose is popular with many users as it supports sleep.
How long before effects are felt?
In clinical trials, improvements in stress and anxiety markers have typically occurred within 4β8 weeks of regular use. Patience is needed β ashwagandha is not a fast-acting compound.
References
Chandrasekhar, K., Kapoor, J., & Anishetty, S. (2012). A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian Journal of Psychological Medicine, 34(3), 255β262. https://pubmed.ncbi.nlm.nih.gov/23439798/
Wankhede, S., Langade, D., Joshi, K., Sinha, S. R., & Bhattacharyya, S. (2015). Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial. Journal of the International Society of Sports Nutrition, 12, 43. https://pubmed.ncbi.nlm.nih.gov/26609282/
Aguiar, S., & Borowski, T. (2013). Neuropharmacological review of the nootropic herb Withania somnifera. Rejuvenation Research, 16(4), 313β326. https://pubmed.ncbi.nlm.nih.gov/23772955/




